Multidrug resistance and extended-spectrum β-lactamases genes among<i>Escherichia coli</i>from patients with urinary tract infections in Northwestern Libya

Abstract

The isolation of MDR ESBL-producing uropathogens undoubtedly will limit the choices clinicians have to treat their patients with UTIs. Therefore, there is an urgent need for surveillance studies on antimicrobial resistance and prevalence of ESBLs among uropathogens to guide the clinical treatment of UTIs in Libya in the future.